Ahmet Kucuk, Erkan Topkan, Esma Didem Ikiz, Nulifer Kılıc Durankus, Sukran Senyurek, Eyub Yasar Akdemir, Duygu Sezen, Yasemin Bolukbasi, Ugur Selek & Berrin Pehlivan·International Research Journal of Oncology·2020
Brain metastases (BMs) represent the commonest intracranial tumours which occur approximately 30% of all adult patients presenting with solid cancers. The BMs do not only reduce the survival expectations but negatively alter the quality of life measures as well. For decades, surg...
Erkan Topkan, Ahmet Kucuk, Nulifer Kilic Durankus, Sukran Senyurek, Eyub Yasar Akdemir, Duygu Sezen, Esma Didem Ikiz, Yasemin Bolukbasi, Berrin Pehlivan & Ugur Selek·International Research Journal of Oncology·2020
Brainstem metastases account only for 3% to 5% of all intracranial metastasis. However, brainstem metastases undoubtedly represent a significant source of severe morbidity and mortality in affected patients with estimated average survival duration of only less than 6 months. Surg...
Erkan Topkan, Ahmet Kucuk, Sukran Senyurek, Duygu Sezen, Nulifer Kilic Durankus, Eyub Yasar Akdemir, Esma Didem Ikiz, Yasemin Bolukbasi, Berrin Pehlivan & Ugur Selek·Journal of Cancer and Tumor International·2020
Brain metastases (BMs), the most frequent intracranial tumors, are diagnosed in approximately 30% of all adult patients over the span of planned treatment against a broad spectrum of solid cancers. The prognosis of patients presenting with BM is bleak with an expected median OS o...
Open access
Research Article10.9734/jcti/2020/v10i130117